Skip to content

The Effect of Lung Ultrasound-Guided Individualized Lung-Protective Ventilation on Atelectasis in Patients Undergoing Laparoscopic Surgery

The Effect of Lung Ultrasound-Guided Individualized Lung-Protective Ventilation on Atelectasis in Patients Undergoing Laparoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118704
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pulmonary complications

Interventions

Group A:During general anesthesia with mechanical ventilation, the ventilation mode is set to volume-controlled ventilation (VCV). A tidal volume (VT) of 7 ml/kg of ideal body weight is used throughou
Group B:During general anesthesia with mechanical ventilation, the ventilation mode was set to volume-controlled ventilation (VCV), using a tidal volume of 7 ml/kg (ideal body weight), 5 cmH2O PEEP, a
Group C:During general anesthesia with mechanical ventilation, the ventilation mode is set to volume-controlled ventilation (VCV). Throughout the procedure, VT is 7 ml/kg (ideal body weight) with 5 cm
Group D:During general anesthesia with mechanical ventilation, the ventilation mode was set to volume-controlled ventilation (VCV) throughout the procedure, using a tidal volume (VT) of 7 ml/kg (ideal

Sponsors

The Second Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) class I to III; 2. Aged 18 to 65 years (inclusive); 3. Patients undergoing laparoscopic cholecystectomy, appendectomy, or herniorrhaphy

Exclusion criteria

Exclusion criteria: 1. Refusal of participation by the patient; 2. American Society of Anesthesiologists (ASA) class > ?; 3. Body mass index (BMI) >= 30 kg/m²; 4. Emergency surgery; 5. A history of thoracic surgery within the recent 6 months; 6. Preoperatively known severe cardiac diseases, including but not limited to severe valvular heart disease, severe cardiomyopathy, severe coronary artery stenosis, a history of unstable angina pectoris, severe cardiac insufficiency (New York Heart Association (NYHA) functional class ? or ?), etc; 7. Preoperative comorbidity of chronic pulmonary diseases, including but not limited to chronic obstructive pulmonary disease (COPD), bronchiectasis, asthma, multiple pulmonary bullae or a single pulmonary bulla > 3 cm in diameter, interstitial pneumonia, cor pulmonale, etc; 8. Preoperative comorbidity of severe hypoproteinemia, hypoxemia, hemoglobin (Hb) < 80 g/L, or thoracic/vertebral spinal deformities affecting ventilation; 9. A history of mental illness or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Incidence of atelectasis within 3 days after surgery;Severity of atelectasis;

Secondary

MeasureTime frame
Lung ultrasound score;Postoperative pulmonary complications(PPCs);Intraoperative respiratory mechanics parameters;Intraoperative hemodynamics;PACU length-of-stay;the time of patient with intubation post-operation;Postoperative hospital stay;

Countries

China

Contacts

Public ContactZhenwei Zheng

The Second Affiliated Hospital of Shantou University Medical College

wind_8228@163.com+86 138 2280 3033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026